Maya Matthews

Lobbying Activity

Meeting with European Patients' Forum (EPF)

24 Nov 2025 · Discussion on EPF’s current activities and planned actions with respect to the Health Technology Assessment Regulation (HTAR) implementation

Meeting with European Organisation for Research and Treatment of Cancer

6 Nov 2025 · Involvement of clinical experts taking part in joint clinical assessments and scientific consultations under the EU Health Technology Assessment (HTA) Regulation

Meeting with

22 Oct 2025 · Exchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation.

Meeting

7 Oct 2025 · Discussion and exchange of views on the application of the Health Technology Assessment Regulation and the international health policy framework

Meeting with EUROPEAN ORGANISATION FOR RARE DISEASES

29 Sept 2025 · Involvement of individual experts, including patients, taking part in joint clinical assessments and scientific consultations under the EU HTA Regulation, as well as capacity-building activities funded by the EU4Health

Meeting with Ultragenyx Europe Gmbh

23 Sept 2025 · Understanding the identification of clinical experts to participate in joint scientific consultations and joint clinical assessments under the EU Regulation on health technology assessment

Meeting with Università Cattolica del Sacro Cuore

25 Jul 2025 · Introduction to the EDiHTA project

Meeting with

24 Jul 2025 · Discuss the input received during the public feedback on the draft Implementing Regulation on joint clinical assessments for medical devices and in vitro diagnostic medical devices

Meeting with European Federation of Pharmaceutical Industries and Associations

3 Jul 2025 · Discussion on implementation of the HTA Regulation with EFPIA HTA Working Group

Meeting with European Society for Paediatric Oncology

20 Jun 2025 · Discussion on the identification of clinical experts to participate in joint scientific consultations and joint clinical assessments under the EU Regulation on health technology assessment.

Meeting with Novartis International AG

3 Jun 2025 · The role of the Commission was here to facilitate the exchange between Novartis and the HTA Coordination Group Chairs about a medicinal product sent for joint clinical assessment

Meeting with European Confederation of Pharmaceutical Entrepreneurs

27 Mar 2025 · EU HTA regulation

Meeting with Global Health Education Group LTD

17 Feb 2025 · Health workforce